FDA Inspection 1014690 — InvaDerm, Inc.

InvaDerm, Inc. — FEI 3010165760

The FDA completed an inspection of InvaDerm, Inc. on Jun 15, 2017 in Somerset, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 15, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Somerset, NJ (United States)

Citations

IDCFRDescription
187921 CFR 211.180(c)Records not made readily available to FDA
191421 CFR 211.166(a)Lack of written stability program
435921 CFR 211.170(b)(1)Retention time of reserve samples, in general
440021 CFR 211.186(b)(8)Description of containers, labels, et. al.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.